SEC 13F Intelligence

Gateway Investment Advisers LLC / ABT

Gateway Investment Advisers LLC’s Abbott Laboratories Position

Does Gateway Investment Advisers LLC own Abbott Laboratories (ABT)? Yes — 403.1K shares worth $41M (+0.46% of its 13F portfolio) as of Q1 2026, down from 486.0K shares the prior filed quarter.

Position Value
$41M
Q1 2026
Shares
403.1K
% of Portfolio
+0.46%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $74MQ4 ’18Q1 ’19: $81MQ2 ’19: $85MQ3 ’19: $80MQ4 ’19: $83MQ4 ’19Q1 ’20: $67MQ2 ’20: $72MQ3 ’20: $79MQ4 ’20: $73MQ4 ’20Q1 ’21: $79MQ2 ’21: $74MQ3 ’21: $75MQ4 ’21: $88MQ4 ’21Q1 ’22: $72MQ2 ’22: $66MQ3 ’22: $58MQ4 ’22: $66MQ4 ’22Q1 ’23: $57MQ2 ’23: $61MQ3 ’23: $55MQ4 ’23: $62MQ4 ’23Q1 ’24: $63MQ2 ’24: $57MQ3 ’24: $62MQ4 ’24: $61MQ4 ’24Q1 ’25: $72MQ2 ’25: $67MQ3 ’25: $65MQ4 ’25: $61MQ4 ’25Q1 ’26: $41Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026403.1K$41M+0.46%
Q4 2025486.0K$61M+0.57%
Q3 2025484.5K$65M+0.63%
Q2 2025490.9K$67M+0.73%
Q1 2025541.2K$72M+0.82%
Q4 2024535.8K$61M+0.67%
Q3 2024547.6K$62M+0.69%
Q2 2024548.2K$57M+0.64%
Q1 2024551.2K$63M+0.71%
Q4 2023565.4K$62M+0.73%
Q3 2023563.5K$55M+0.69%
Q2 2023563.8K$61M+0.72%
Q1 2023564.0K$57M+0.70%
Q4 2022604.9K$66M+0.82%
Q3 2022600.7K$58M+0.73%
Q2 2022606.7K$66M+0.74%
Q1 2022604.5K$72M+0.71%
Q4 2021621.9K$88M+0.84%
Q3 2021636.5K$75M+0.78%
Q2 2021636.1K$74M+0.76%
Q1 2021660.0K$79M+0.86%
Q4 2020670.3K$73M+0.80%
Q3 2020728.5K$79M+0.92%
Q2 2020788.4K$72M+0.85%
Q1 2020845.5K$67M+0.82%
Q4 2019952.9K$83M+0.82%
Q3 2019961.4K$80M+0.81%
Q2 20191.01M$85M+0.77%
Q1 20191.01M$81M+0.72%
Q4 20181.02M$74M+0.70%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gateway Investment Advisers LLC’s full portfolio or all institutional holders of ABT.